Api

The fundamentals of the company should be judged based on the specialty pipeline and a strong footing in the domestic market

Ami Organics | Strong growth runway for the CDMO business? | Stock of the Day

Ami Organics gets 87 percent of the revenue comes from pharma space wherein it manufactures intermediates for APIs and NCE (New Chemical Entities). Rest of the revenue comes from chemicals segment. While company’s foray into the lithium-ion batteries and the semiconductor industry value chain is a key watch, ramp-up in CDMO (Contract Development and Manufacturing Organization) contracts is expected to be the key earnings catalyst. In the recent quarterly result, there was a sharp pick up in the CDMO business. At the same time, guidance for next three years suggest that high growth phase to sustain.

Bajaj Healthcare rises after CDMO pact for 15 new Active Pharma Ingredients

The new APIs are in addition to a contract for 15 molecules for the client signed earlier this year. Bajaj Healthcare said the new CDMO pipeline comprises of off-Patent generic APIs as well as APIs that are still under patent.

Healthcare, pharma deal values fall 67% YoY in March quarter: GT Bharat

The quarter also reported four IPOs totaling $466 million, a doubling in volumes compared to the previous quarter

Decoded: Sebi's proposed rules to regulate algo trading by retail traders

SEBI is concerned that algo developers promise lofty returns to gullible traders, and bypass SEBI rules applicable to registered investment advisors (RIA) as mandated by SEBI. Misselling too is a huge problem.

Ami Organics: Should one look beyond the sharp pricing erosion?

The pharma company is well positioned to take advantage of emerging opportunities

Ami Organics: Fermion contract raises FY25 earnings visibility

Capex in Ankleshwar, pick-up in supplies for Fermion and a foray into the electro-lyte additive business are the other factors prompting the company to expect a bounce-back in growth in FY25.

Concord Biotech: This niche API play rides on China-plus theme

The company has a good repute in the fermentation-based API segment. A number of fermentation-based biologic drugs are expected to lose exclusivity in the next two years, and this opens a $60 billion opportunity.

62% increase in API attacks on Indian financial sector: CERT-In joint white paper

The majority of cyber attacks on APIs deployed in the Indian financial sector was due to security misconfiguration, the joint white paper by CERT-In, Mastercard, and CSIRT-Fin said

Google announces new sustainability APIs for Maps

Google says companies can use these APIs to provide up-to-date environmental information to customers.

Ami Organics: Opportunities in battery value chain not priced in

Pickup in collaboration between global pharma majors and Indian firms for pharma ingredients/molecules, development of new products among positives.

Lupin may spin off API business as part of business recast to unlock value

Glenmark Pharma had undergone a similar exercise in May 2019, when it spun off its API business into a new entity called Glenmark Life Sciences, which made its public market debut in August 2021

Sun Pharma: Stretched valuation a sticking point, what else to watch out for?

Elevated promotional/travel expenses and increased competitive intensity would weigh on margins

Balaji Amines: Does it merit a look?

Key monitorable to watch would be sustenance of operating margins for the subsidiary - Balaji Specialty

Race for Glenmark Life Sciences: Blackstone, KKR, BPEA EQT, PAG and Nirma Group likely suitors

Glenmark Pharma, the parent company that holds 82.85% stake in Glenmark Life, is looking to reduce its debt burden via the stake sale process, say sources

Reddit ready to make some serious money, AI firms have to pay to use its content

A lot of companies use Reddit as a training ground for AI language models. Founder Steve Huffman has said Reddit data is really valuable" and there is no need to give all that to "some of the largest companies in the world for free"

OpenAI begins bug bounty program for ChatGPT

Up to $20,000 up for grabs for people who disclose security bugs in OpenAI's APIs.

OpenAI adds plugin support to ChatGPT

With plugins, ChatGPT will be able to pull more relevant and up-to-date information and also allow developers to integrate the chatbot with their APIs

Europe points out deficiencies at Biocon’s Bengaluru bulk drug plant

While no deficiencies were marked as critical, one was categorised as major, the company said in a stock exchange filing.

Over 193 million cyber attacks on APIs in India between December '21 and April 22: Akamai

Akamai attributed the rise in attacks on APIs in the financial sector to the embracing of Open Banking in India’s banking system

Pharma industry faces inflation-induced slowdown: Alembic Pharmaceutical CFO

In the past, during a high inflation period, pharma sales have gone down, says RK Baheti. But with the steps taken by the government in the last two weeks, he believes inflation will be reined in to an extent

Sequent Scientific hits 22-month low after weak earnings

The firm reported a net profit of Rs 10.04 crore in the March quarter, down 57.34% from Rs 23.52 crore a year ago. Revenue rose 6% from a year ago to Rs 383.71 crore.

Divi’s Labs: Steady margin profile amid cost headwind

Earnings trigger for the medium term is Contrast Media API opportunity, where there is limited competition

Google and Samsung partners to let developers sync fitness data across Android apps

The hub would require a user's approval before the syncing takes place

Pfizer opens $20-million global drug development centre at IIT-Madras

The centre, the first in Asia, will be a part of a network of 12 such facilities to be set up worldwide